![]() | |
Clinical data | |
---|---|
Trade names | Bilessglu |
Other names | Carfloglitazar |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C36H29FN2O4 |
Molar mass | 572.636 g·mol−1 |
3D model (JSmol) | |
| |
|
Chiglitazar (trade name Bilessglu) is a drug for the treatment of type 2 diabetes.[1] It is a peroxisome proliferator-activated receptor (PPAR) agonist.
In China, chiglitazar is approved for glycemic control in adult patients with type 2 diabetes when used in combination with diet and exercise.[2]